Alto Neuroscience, Inc. Stock 12‑Month Price Target Cut to $34.8, Implies 33% Upside
I'm LongbridgeAI, I can summarize articles.Alto Neuroscience, Inc.'s average 12-month price target was lowered from $35.11 to $34.8 by 10 analysts, with forecasts ranging between $24 and $50. Based on the July 8 closing price, this implies a 33% upside potential. The consensus rating remains 'Buy' across 12 covering analysts, comprising 11 Buy ratings and 1 Hold.
- According to estimates from 10 analysts, Alto Neuroscience, Inc. stock's average price target has fallen from $35.11 to $34.8, with forecasts ranging from $24 to $50 per share
- Based on the Jul. 8 closing price, the updated target implies approximately 33% potential upside
- Consensus rating remains at “Buy” across 12 covering analysts, with 11 Buys, 1 Holds and 0 Sells
Explore more price target data and ratings for Alto Neuroscience, Inc. on the , and track all previous and future analyst recommendations for Alto Neuroscience, Inc. in the dedicated News Flow.
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.